Numerous epidemiological studies and large meta-analyses have convincingly shown evidence for the association between higher plasma levels of a number of the inflammatory proteins coded for by inflammatory genes (most extensively, C-reactive protein [CRP] but also some members of the interleukin family) and CHD risk. This evidence concerns the gene CRP and coronary artery disorder.